NCT04249908View on ClinicalTrials.gov

Pharmacokinetics of Besifovir in Adults With Normal and Impaired Renal Function

PHASE1UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 13, 2020

Primary Completion Date

September 30, 2020

Study Completion Date

April 30, 2021

Conditions
Renal Impairment
Interventions
DRUG

Besifovir Dipivoxil Maleate

Besifovir 150 mg q.d.

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT04249908 - Pharmacokinetics of Besifovir in Adults With Normal and Impaired Renal Function | Biotech Hunter | Biotech Hunter